Sapio Sciences, the science-awareTM lab informatics platform, announced a strategic partnership with Ultima Genomics. The collaboration will make m...
Corner Therapeutics, an in vivo T cell modulation and immunotherapy company pioneering novel approaches to cancer and infection, published research in mB...
Two leaders in lipid nanoparticle (LNP) development have partnered to make PEG-free shielding lipids available to researchers advancing LNPs for non-vira...
Valneva SE , a specialty vaccine company, announced that the United States Food and Drug Administration (FDA) has suspended the license for IX...
ViRx@Stanford, a leading biosecurity and pandemic preparedness initiative, and Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), an innovati...
-PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announ...
Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, doubl...
POP Biotechnologies (POP BIO), a biotechnology company specializing in nanoparticle-based vaccines, and the Coalition for Epidemic Preparedness Innovatio...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced that the European Medicines Agency (EMA) will lift the tempo...
Valneva SE, , a specialty vaccine company, announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companie...
Agreement builds on PharmaJet’s strategy to be the best-in-class delivery system for novel DNA- and RNA-based vaccines and immunotherapies usin...
Sinovac Biotech Ltd. (NASDAQ: SVA), a prominent player in China's biopharmaceutical sector, has entered a defining phase in its corporate history. As the...
Valneva SE , a specialty vaccine company, announced positive six-month antibody persistence and safety data for its Phase 2 clinical trial evaluatin...
Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with improve...
© 2025 Biopharma Boardroom. All Rights Reserved.